Your browser doesn't support javascript.
loading
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Jakob, Carolin E M; Borgmann, Stefan; Duygu, Fazilet; Behrends, Uta; Hower, Martin; Merle, Uta; Friedrichs, Anette; Tometten, Lukas; Hanses, Frank; Jung, Norma; Rieg, Siegbert; Wille, Kai; Grüner, Beate; Klinker, Hartwig; Gersbacher-Runge, Nicole; Hellwig, Kerstin; Eberwein, Lukas; Dolff, Sebastian; Rauschning, Dominic; von Bergwelt-Baildon, Michael; Lanznaster, Julia; Strauß, Richard; Trauth, Janina; de With, Katja; Ruethrich, Maria; Lueck, Catherina; Nattermann, Jacob; Tscharntke, Lene; Pilgram, Lisa; Fuhrmann, Sandra; Classen, Annika; Stecher, Melanie; Schons, Maximilian; Spinner, Christoph; Vehreschild, Jörg Janne.
  • Jakob CEM; Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Borgmann S; German Center for Infection Research (DZIF), Brunswick, Germany.
  • Duygu F; Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany.
  • Behrends U; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, Frankfurt, Germany.
  • Hower M; German Center for Infection Research (DZIF), Brunswick, Germany.
  • Merle U; Technical University Munich, Children's Hospital, Munich, Germany.
  • Friedrichs A; Research Unit Gene Vectors, Helmholtz Zentrum Muenchen, Munich, Germany.
  • Tometten L; Clinic for Pneumology, Infectiology, Internal Medicine and Intensive Care, Hospital Dortmund gGmbH, Dortmund, Germany.
  • Hanses F; Department of Gastroenterology and Infectiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jung N; Department of Internal Medicine, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Rieg S; Department of Gastroenterology and Infectiology, Klinikum Ernst-von-Bergmann, Potsdam, Germany.
  • Wille K; Emergency Department, University Hospital Regensburg, Regensburg, Germany.
  • Grüner B; Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Klinker H; Department of Medicine II, University of Freiburg, Freiburg, Germany.
  • Gersbacher-Runge N; University Clinic for Haematology, Oncology, Haemostaseology and Palliative Care, University of Bochum, Minden, Germany.
  • Hellwig K; Division of Infectious Diseases, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Eberwein L; Division of Infectious Diseases, Department of Medicine II, University of Würzburg Medical Center, Würzburg, Germany.
  • Dolff S; Center of Infectiology Berlin/Prenzlauer Berg, Berlin, Germany.
  • Rauschning D; Department of Neurology, Katholisches Klinikum Bochum, Ruhr University Bochum, Bochum, Germany.
  • von Bergwelt-Baildon M; 4th Department of Internal Medicine, Klinikum Leverkusen gGmbH, Leverkusen, Germany.
  • Lanznaster J; Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Strauß R; Bundeswehr Central Hospital, Koblenz, Germany.
  • Trauth J; Department of Internal Medicine III, Ludwig Maximilians University, Munich, Germany.
  • de With K; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
  • Ruethrich M; Bavarian Center for Cancer Research (BZKF), Munich, Germany.
  • Lueck C; 2nd Medical Clinic, Hospital Passau, Passau, Germany.
  • Nattermann J; Department of Medicine 1, University Hospital Erlangen, Erlangen, Germany.
  • Tscharntke L; Medical Clinic II, University Hospital Gießen, Giessen, Germany.
  • Pilgram L; Division of Infectious Diseases, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
  • Fuhrmann S; Department of Internal Medicine II, University Hospital Jena, Jena, Germany.
  • Classen A; Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Stecher M; German Center for Infection Research (DZIF), Brunswick, Germany.
  • Schons M; Department of Internal Medicine I, UKB University Hospital Bonn, Bonn, Germany.
  • Spinner C; Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Vehreschild JJ; Department of Internal Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany.
Infection ; 49(1): 63-73, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33001409
ABSTRACT

PURPOSE:

Knowledge regarding patients' clinical condition at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection is sparse. Data in the international, multicenter Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS) cohort study may enhance the understanding of COVID-19.

METHODS:

Sociodemographic and clinical characteristics of SARS-CoV-2-infected patients, enrolled in the LEOSS cohort study between March 16, 2020, and May 14, 2020, were analyzed. Associations between baseline characteristics and clinical stages at diagnosis (uncomplicated vs. complicated) were assessed using logistic regression models.

RESULTS:

We included 2155 patients, 59.7% (1,287/2,155) were male; the most common age category was 66-85 years (39.6%; 500/2,155). The primary COVID-19 diagnosis was made in 35.0% (755/2,155) during complicated clinical stages. A significant univariate association between age; sex; body mass index; smoking; diabetes; cardiovascular, pulmonary, neurological, and kidney diseases; ACE inhibitor therapy; statin intake and an increased risk for complicated clinical stages of COVID-19 at diagnosis was found. Multivariable analysis revealed that advanced age [46-65 years adjusted odds ratio (aOR) 1.73, 95% CI 1.25-2.42, p = 0.001; 66-85 years aOR 1.93, 95% CI 1.36-2.74, p < 0.001; > 85 years aOR 2.38, 95% CI 1.49-3.81, p < 0.001 vs. individuals aged 26-45 years], male sex (aOR 1.23, 95% CI 1.01-1.50, p = 0.040), cardiovascular disease (aOR 1.37, 95% CI 1.09-1.72, p = 0.007), and diabetes (aOR 1.33, 95% CI 1.04-1.69, p = 0.023) were associated with complicated stages of COVID-19 at diagnosis.

CONCLUSION:

The LEOSS cohort identified age, cardiovascular disease, diabetes and male sex as risk factors for complicated disease stages at SARS-CoV-2 diagnosis, thus confirming previous data. Further data regarding outcomes of the natural course of COVID-19 and the influence of treatment are required.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus / Pandemias / COVID-19 / Enfermedades Renales / Enfermedades Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus / Pandemias / COVID-19 / Enfermedades Renales / Enfermedades Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article